Skip to main content
logo
Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
8.62
+0.07 (0.82%)
Aug 10, 2026, 11:08 AM EDT - Market open

Phathom Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
239.66175.1155.250.68--
Revenue Growth
110.16%216.93%8001.47%---
Gross Profit
198.73152.5147.280.52--
Operating Income
-40.64-159.99-277.47-167.31-172.44-135.08
Net Income
-99.07-221.25-334.33-201.59-197.72-143.88
Earnings Per Share
-1.28-3.03-5.29-3.93-5.05-3.89
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
182.48129.97297.26381.39155.39183.26
Total Debt
167.11211.8201.91139.0397.0791.34
Net Cash (Debt)
15.37-81.8395.35242.3658.3291.92
Net Cash Growth
---60.66%315.61%-36.56%-61.46%
Net Cash Per Share
0.20-1.121.514.731.492.48

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-36.69-166.78-266.77-137.58-146.53-148.46
Capital Expenditures
-0.22-0.23-0.14-1.63-1.04-0.33
Free Cash Flow
-36.91-167-266.91-139.21-147.57-148.79
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
82.92%87.09%85.57%75.51%--
Operating Margin
-16.96%-91.36%-502.18%-24532.60%--
Pretax Margin
-41.34%-126.35%-605.09%-29558.94%--
Profit Margin
-41.34%-126.35%-605.09%-29558.90%--
FCF Margin
-15.40%-95.37%-483.07%-20412.60%--

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
2.896.7710.07776.05--